Christian M Jespersen
Overview
Explore the profile of Christian M Jespersen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
227
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kjoller E, Hilden J, Winkel P, Galatius S, Frandsen N, Jensen G, et al.
Am Heart J
. 2014 Jul;
168(2):197-204.e1-4.
PMID: 25066559
Unlabelled: The objective of this study is to describe the agreement between randomized trial outcome assessment by committee and outcomes entirely identified through public registers. Methods: In the CLARICOR trial,...
2.
Song H, von Heymann C, Jespersen C, Karkouti K, Korte W, Levy J, et al.
Ann Thorac Surg
. 2014 Mar;
97(5):1630-5.
PMID: 24655469
Background: Perioperative red blood cell transfusion is associated with adverse outcomes after cardiac operations. Although restrictive transfusion protocols have been developed, their safety and efficacy are not well demonstrated, and...
3.
Karkouti K, von Heymann C, Jespersen C, Korte W, Levy J, Ranucci M, et al.
J Thorac Cardiovasc Surg
. 2013 Jul;
146(4):927-39.
PMID: 23820174
Objectives: Cardiac surgery with cardiopulmonary bypass frequently leads to excessive bleeding, obligating blood product transfusions. Because low factor XIII (FXIII) levels have been associated with bleeding after cardiac surgery, we...
4.
Kjoller E, Hilden J, Winkel P, Frandsen N, Galatius S, Jensen G, et al.
J Clin Epidemiol
. 2012 Jan;
65(4):444-53.
PMID: 22257841
Objective: In clinical trials, agreement on outcomes is of utmost importance for valid estimation of intervention effects. As there is limited knowledge about adjudicator agreement in cardiology, we examined the...
5.
Winkel P, Hilden J, Hansen J, Hildebrandt P, Kastrup J, Kolmos H, et al.
Cardiology
. 2011 Mar;
118(1):63-7.
PMID: 21447948
Objectives: To elucidate potential mechanisms for the clarithromycin-induced excess mortality observed in the CLARICOR trial during 2.6 year follow-up of patients with stable coronary artery disease. Methods: Cox analyses using...
6.
Harutyunyan M, Mathiasen A, Winkel P, Gotze J, Hansen J, Hildebrandt P, et al.
Scand J Clin Lab Invest
. 2010 Nov;
71(1):52-62.
PMID: 21108561
Background: Patients with stable coronary artery disease (CAD) have a poor prognosis. The aim of the study was to evaluate the extent to which serum high-sensitivity C-reactive protein (hs-CRP) and...
7.
Hilden J, Lind I, Kolmos H, Als-Nielsen B, Damgaard M, Hansen J, et al.
Diagn Microbiol Infect Dis
. 2010 Mar;
66(4):385-92.
PMID: 20226329
The association observed between coronary heart disease (CHD) and Chlamydia (Chlamydophila) pneumoniae antibodies prompted, during the 1990s, several primary and secondary prevention trials with various antibiotics. In our CLARICOR trial,...
8.
Jensen G, Hilden J, Als-Nielsen B, Damgaard M, Hansen J, Hansen S, et al.
J Cardiovasc Pharmacol
. 2009 Nov;
55(2):123-8.
PMID: 19920766
In the CLARICOR trial, significantly increased cardiovascular (CV) and all-cause mortality in stable patients with coronary heart disease were observed after a short course of clarithromycin. We report on the...
9.
Levy J, Gill R, Nussmeier N, Olsen P, Andersen H, Booth F, et al.
Thromb Haemost
. 2009 Oct;
102(4):765-71.
PMID: 19806264
Bleeding following cardiac surgery involving cardiopulmonary bypass (CPB) remains a major concern. Coagulation factor XIII (FXIII) functions as a clot-stabilising factor by cross-linking fibrin. Low post-operative levels of FXIII correlate...
10.
Kastrup J, Johansen J, Winkel P, Hansen J, Hildebrandt P, Jensen G, et al.
Eur Heart J
. 2009 Mar;
30(9):1066-72.
PMID: 19270316
Aims: Macrophages in atherosclerotic plaques secrete YKL-40. We tested the hypothesis if high serum YKL-40 concentration predicts coronary events and death of patients with stable coronary artery disease (CAD). Methods...